SARS-CoV-2 Spike-Binding Antibody Longevity and Protection from Reinfection with Antigenically Similar SARS-CoV-2 Variants
Article
[키워드] acute respiratory syndrome
advanced age
analyzed
antibodies
antibody
antibody durability
Antibody titer
circulation
Cohort
collected
convalescent
coronavirus
coronavirus disease
COVID-19
decrease
detectable
determine
Effectiveness
Enrollment
exceptional
female
Health care worker
highlight
immune responses
Increases
Infection
initial
limit
Longevity
median
modeling
mounted
new SARS-CoV-2
occurred
Pandemics
participant
Participants
protection
public health crisis
Rapid
Reinfection
risk
SARS-CoV-2
SARS-CoV-2 antibody
SARS-COV-2 infection
SARS-CoV-2 variant
seronegative
seropositive
seropositive participant
severe COVID-19
Sex
spike-binding antibodies.
stability
Steady state
vaccination
variants of concern
viruses
[DOI] 10.1128/mbio.01784-22 PMC 바로가기
[DOI] 10.1128/mbio.01784-22 PMC 바로가기